Here, we describe medicinal chemistry that was accelerated by a diversity-oriented synthesis (DOS) pathway, and in vivo studies of our previously reported macrocyclic antimalarial agent that derived from the synthetic pathway. Structure–activity relationships that focused on both appendage and skeletal features yielded a nanomolar inhibitor of P. falciparum asexual blood-stage growth with improved solubility and microsomal stability and reduced hERG binding. The build/couple/pair (B/C/P) synthetic strategy, used in the preparation of the original screening library, facilitated medicinal chemistry optimization of the antimalarial lead.
Diversity-Oriented Synthesis-Facilitated Medicinal Chemistry: Toward the Development of Novel Antimalarial Agents
Eamon Comer,Jennifer A. Beaudoin,Nobutaka Kato,M. Fitzgerald,Richard W. Heidebrecht,Maurice D Lee,Daniela Masi,M. Mercier,Carol A. Mulrooney,Giovanni Muncipinto,Ann M. Rowley,Keila Crespo-Llado,A. Serrano,A. Lukens,R. Wiegand,D. Wirth,M. Palmer,M. Foley,B. Muñoz,Christina A Scherer,Jeremy R. Duvall,S. Schreiber
Published 2014 in Journal of Medicinal Chemistry
ABSTRACT
PUBLICATION RECORD
- Publication year
2014
- Venue
Journal of Medicinal Chemistry
- Publication date
2014-09-11
- Fields of study
Medicine, Chemistry
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-18 of 18 references · Page 1 of 1
CITED BY
Showing 1-37 of 37 citing papers · Page 1 of 1